Announced details
Topical analgesics and self-care for muscle and joint pain and discomfort
Pain Away was launched in Australia in 1999 and has become widely familiar to consumers. Specific usage figures and other details are not disclosed.
Transferor. Mentholatum Australasia Pty Ltd., Rohto Pharmaceutical's Australian subsidiary, will acquire the business rights, intellectual property rights and other assets. Capital and personnel relationships are not disclosed.
An Australian consumer health company. Other information, including its location, representative, stated capital and year of establishment, is not disclosed.
MAUS's headquarters and manufacturing facility: Victoria, Australia
The impact on consolidated results for the current fiscal year will be minor. The Company expects the transaction to contribute to increasing corporate value over the medium to long term.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Pain Away, Deep Heat |
| Counterparty | Wellnex Life Limited（ASX／AIM：WNX） |
| Counterparty overview | An Australian consumer health company. Other information, including its location, representative, stated capital and year of establishment, is not disclosed. |
| Relationship with the Company | Transferor. Mentholatum Australasia Pty Ltd., Rohto Pharmaceutical's Australian subsidiary, will acquire the business rights, intellectual property rights and other assets. Capital and personnel relationships are not disclosed. |
| Contract Date | 6 August 2026 (the decision to enter into the agreement was approved by the Board of Directors on the same date; the date on which the agreement itself will be executed is not disclosed) |
| Applicable area | Topical analgesics and self-care for muscle and joint pain and discomfort |
| Location | MAUS's headquarters and manufacturing facility: Victoria, Australia |
| Usage history | Pain Away was launched in Australia in 1999 and has become widely familiar to consumers. Specific usage figures and other details are not disclosed. |
| Impact on Business Performance | The impact on consolidated results for the current fiscal year will be minor. The Company expects the transaction to contribute to increasing corporate value over the medium to long term. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The transaction is intended to strengthen the self-care business in Australia by leveraging both the existing Deep Heat and Pain Away brands and integrating product development, sales, marketing, manufacturing and logistics. The Company expects the transaction to contribute to increasing corporate value over the medium to long term.